Objectives: Chronic rhinosinusitis (CRS) results in significant morbidity and healthcare expenditure. The safety and effectiveness of nasal irrigation for the treatment of pediatric CRS has been demonstrated, but its long-term outcomes are unknown. This study's goals were to assess the effectiveness of nasal irrigation after first-time use for pediatric CRS and to determine the short-and long-term outcomes of treating nasal symptoms with irrigation.
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Introduction
Acute and chronic rhinosinusitis are a common cause of significant morbidity and healthcare expenditure. These conditions affect the quality of life (QoL) for both pediatric and adult populations. An analysis of the National Health Interview Survey between 1997 and 2006 found that sinusitis affects 15.2% of the United States' population annually. 1 The national healthcare costs due to chronic rhinosinusitis (CRS) are estimated to be $8.6 billion annually. 2 Rhinosinusitis is a common concern in the pediatric population. Children typically have six to eight respiratory viral infections per year. An estimated 0.5-5% of these cases proceed to acute rhinosinusitis, and an unknown number of these children will develop CRS. 3 If left untreated, these conditions could lead to long-term symptoms, such as nasal airway obstruction, congestion, rhinorrhea, cough, headache, and daytime fatigue. Rhinosinusitis can adversely affect the lives of children and their caretakers due to missed school and work days, respectively, and increase need to utilize the health care system. Children with CRS were perceived by their parents to have significantly more physical pain and debilitation compared to children with other chronic diseases, such as asthma and juvenile rheumatoid arthritis. 4 Several treatment options for pediatric CRS currently exist with varying efficacies and risk. Treatments for CRS may also depend on addressing underlying co-morbidities such as allergies. Therapies for CRS are divided into medical and surgical options. Medical therapies have traditionally included antibiotics, corticosteroid and antihistamine nasal sprays, and nasal irrigation. Traditionally, antibiotics have been considered the first-line medical treatment for CRS. However, while they are frequently prescribed, antibiotics do not have any Level 1 evidence in effectively treating this disease. 5 Their ineffectiveness is believed to be because CRS is not due to an acute bacterial infection. The circumferential mucosal thickening on computed tomography is reflective of chronic inflammation. 6 Any bacterial infection associated with CRS is considered secondary to the pathophysiology of CRS, so antibiotics alone would not improve this condition.
Given the underlying inflammatory mechanism, the use of oral corticosteroids has shown to reduce the size of nasal polyps to improve drainage and symptoms. A meta-analysis of the use of oral corticosteroids for the treatment of CRS concluded that oral steroids can be effective in treating CRS associated with nasal polyps. 7 However, its use has insufficient evidence for treating CRS without nasal polyps because they have not been shown to directly reduce the chronic inflammation within the blocked sinuses. No other medications were included in the meta-analysis. 7 An alternative approach is the use of nasal irrigation, which has been shown to directly cleanse the nasal mucosa and promote mucus excretion. 8, 9 It also removes inflammatory mediators 10, 11 and improves ciliary beat frequencies. 12, 13 Several studies have examined the efficacy of nasal irrigations in alleviating sinus symptoms in pediatric patients. An RCT comparing saline or saline with gentamycin showed that nasal irrigation was well-tolerated, with over 95% compliance during a 6 week treatment course, and significantly improved the quality of life as measured by the Sinonasal 5 (SN-5) survey. 6 The most commonly reported minor adverse events include post-irrigation nasal drainage and initial discomfort, 14 though rare cases of nosebleeds and stinging have been reported. 15 Other studies have also reported the safety of irrigation without any serious adverse effects, while minor adverse events can be avoided by modifying one's technique. 16 A meta-analysis on the use of nasal irrigation for the treatment of CRS concluded that its benefits outweighed its adverse effects. 12 Several systematic reviews have since recognized nasal irrigation as a treatment for CRS symptoms. [17] [18] [19] In a small study of adults with CRS, 52.5% of them were reported to be refractory to medical treatment and needed to consider surgical procedures. 20 Although the refractory rate in the pediatric CRS population remains unknown, surgical procedures are still considered for those that fail medical therapies. The reported success rate for adenoidectomies in the treatment of pediatric CRS is estimated to be 60-70% in multiple small single site studies. 21, 22 Functional endoscopic sinus surgery (FESS) reported to have an estimated success rate of 88% based on a meta-analysis of over 800 pediatric CRS patients. 23 FESS has also been reported to significantly improve quality of life for patients. 24 However, 3% of patients that undergo FESS experience major complications, such as uncontrolled bleeding and periorbital bruising. follow-up of parental acceptance. This study's goals were to assess the effectiveness of nasal irrigation after first-time use for pediatric CRS and to determine the short-and long-term outcomes of treating nasal symptoms using irrigation.
Materials and Methods

Study Design
This was a two-part study. First, we performed a retrospective cohort study on patients under 18 years of age with an established diagnosis of CRS based on history and CT imaging by a single pediatric otolaryngologist and for whom a 6-week course of nasal irrigation was recommended. Second, we surveyed parents from 1 to 9 years later to assess sustained use and outcomes of nasal irrigation for recurrent symptoms.
The patients were identified using ICD-9 code from an EMR for chronic sinusitis receiving an individual score. Along with frontal, maxillary, and sphenoid sinuses, a score of 2 is also given in the case of osteomeatal obstruction. 26 A cumulative score of 5 or higher provides a sensitivity and specificity of 86% and 85%, respectively. 27 We reviewed symptoms resolution rates as reported by patients and families as well as need for adenoidectomy and/or FESS after the initial irrigation period.
For the follow-up survey, parents or primary caretakers from the specified patient population were contacted between October 2012 and January 2013. This study proposal was approved by the KUMC Institutional Review Board, after which a list of pediatric CRS patients was obtained.
Results
We identified 144 potential subjects during the study period. Forty patients were excluded for the following reasons: 12 did not tolerate irrigation, 2 did not have a confirmed CRS diagnosis, 3 were not prescribed nasal irrigation, and 23 were lost to short-term follow-up.
A total of 104 patients were included in this study, with 65.4% being males. All patients underwent at least 6 weeks of daily nasal irrigation. In Table 1 , the distribution of baseline characteristics were compared between the two groups (long-term follow-up versus no long-term follow-up). The mean age at first visit to the pediatric otolaryngologist was 8.0 years (IQR: 5.00-9.88). The most commonly reported symptoms include chronic nasal congestion, intermittent or persistent cough, and rhinorrhea. Comorbid conditions include positive allergy tests, asthma, and previous diagnosis of gastroesophageal reflux disease (GERD). All study subjects had tried antibiotics prior to referral to the pediatric otolaryngologist.
The mean number of courses of antibiotic therapy completed in the previous 6 months (n=37) was 3.59 ± 1.99 and in the previous 12 months (n=26) was 5. Median number of times irrigation was used during long-term follow-up was 1(IQR 0-3), and median duration of irrigation was 1 week (IQR 0-2). Of the 54 patients we were able to contact for the long-term follow-up, an additional 3 patients underwent FESS that did not receive it following the initial 6 week regimen of nasal irrigation. Median length of follow-up for this cohort was 48 months (range 20-113). 
Discussion
The goals of this study were to report on the efficacy of daily nasal irrigation after firsttime use for pediatric CRS and to determine the short-and long-term outcomes of treating nasal symptoms using irrigation. Of the patients that had short-term follow-up after the initial use of irrigation, 65.9% of patients reported complete resolution of symptoms, and 12.1% patients underwent limited FESS due to persistent clinical symptoms. On long-term follow-up, 61.1% of families that completed the survey reported self-initiated use of nasal irrigation for recurring symptoms, and an additional 3 patients were found to have undergone FESS during the followup period of up to almost 4 years.
Based on reported resolution of symptoms, reduction of Lund-Mackay Scores on CT imaging, and minimal need for sinus surgery, once daily saline irrigation is an effective treatment for pediatric CRS. Parents and caretakers are likely to use nasal irrigation for subsequent or recurrent nasal symptoms after initial experience with nasal irrigation. Despite using a wide variety of medications, our study population continued to have chronic symptoms until nasal irrigation was used. Therefore, irrigation might well be a suitable first line treatment for pediatric CRS.
The statistically significant reductions in Lund-Mackay scores in our study population after once daily nasal irrigation reflects the reversal of mucosal thickening and return to sinonasal health from nasal irrigation alone without additional medical therapies. A previous randomized clinical trial of nasal irrigation compared saline versus saline plus gentamycin and showed statistically significant reductions of about 4 points in Lund-Mackay CT scores of sinuses on either side. This reduction was shown to be correlated with improvements in QoL as measured by the sinonasal 5 (SN-5) questionnaires before and after treatment. 6 Our study also found statistically significant reductions of over 4 points of Lund-Mackay scores on each the left sinuses and right sinuses. Unfortunately, the patients' medical records did not contain any information on them having completed the SN-5 surveys, so it was not reported in our study.
Our previous trial emphasized that CT findings of opacification in paranasal sinuses represent mucosal thickening and not acute bacterial sinusitis since there are no air-fluid levels. 6 Unless there is complete opacification in the maxillary sinuses, one will almost always see that the opacification is circumferential, reflecting the thickened mucosa. It would appear that the paranasal sinus system parallels the human middle ear and mastoid system. In the latter, we know that lack of aeration/oxygenation through the normal functioning of Eustachian tubes often leads to middle ear mucosal metaplasia and hypertrophy, increased goblet cells, and subsequent secretion of mucoid effusion. It seems logical that when the nasal mucosa becomes congested and hypertrophic, the natural ostia and ostiomeatal complex are obstructed, leading to subsequent hypoxia and lack of oxygenation in the paranasal sinuses. This change in the paranasal sinuses ultimately leads chronic mucosal inflammation.
This larger cohort had similar patient characteristics compared to the smaller group of 40 patients in the previous clinical trial with a mean age of approximately 8 years for children diagnosed with CRS. 6 In our study, the most commonly presenting symptoms are nasal congestion, cough, and rhinorrhea and match the most common symptoms in prior studies. 3, 6 Despite the chief complaints of nasal stuffiness and congestion, upon physical exam, rhinorrhea is inconsistently observed, even with flexible fiberoptic nasal endoscopy and nasopharyngoscopy in the office setting. Parents, caretakers, and patients typically report either a white or cloudy and rarely yellowish rhinorrhea or purulent. As rigid nasal endoscopy in pediatric patients is oftentimes difficult, purulent drainage from the middle meatus is rarely visualized. 28 The lack of purulent rhinorrhea emphasizes our assertion that pediatric CRS is an inflammatory process and not active "bacterial" infection. Hence, clinical symptoms are rarely responsive to systemic antibiotic therapy and even prolonged courses of 21 days of broad-spectrum antibiotics, which are often prescribed when there is CT evidence of sinus opacification.
Asthma, allergies, and gastroesophageal reflux disease (GERD) have been reported to be the most common co-morbidities associated with CRS, with most patients report having been prescribed systemic and nasal steroids and antihistamines prior to visiting to otolaryngology. 16 Our study population also demonstrated that allergies, asthma, and GERD are common comorbidities. We report asthma as the most common medical-comorbidity in this group of children, with over half having been diagnosed and treated for asthma. Approximately 50% of the patients had positive skin allergy tests to common aeroallergens. A previous trial had reported asthma in about half of the study population, and atopy, in about 73%. 6 These differences may simply reflect the minor dissimilarities. Parental/caretaker report of previously diagnosed and/or treated GERD was lower in this larger group, at only 27% compared to the previously reported 45% in only 40 children. 6 As such, it is important to ask parents/caretakers regarding history of skin allergy testing as well as results of testing if performed and, in children who are old enough, whether diagnosis of asthma has been made based on objective testing such as spirometry or pulmonary function test with methacholine challenge. Many otherwise healthy school-aged children are now prescribed bronchodilator therapy for symptoms of chronic cough, perhaps, for the presumed diagnosis of "cough-variant asthma." If there is mucosal thickening representative of inflammation in the paranasal sinuses, then the sinopulmonary reflex may be responsible for the cough and reversal of mucosal inflammation is likely necessary for complete resolution of chronic cough. For those patients presenting with symptoms suggestive of CRS who have not had allergy evaluation, evaluation and testing is strongly recommended. If the testing is negative for allergies, it is important to counsel families on the opportunity for their children not to consume medications unnecessarily. A previous trial demonstrated a 94% compliance rate with the 6 week daily nasal irrigation regimen. 6 The high compliance with and self-initiated use of nasal irrigation reflects the high motivation on the part of the parents/caretakers in hopes of avoiding any need for FESS as well as desire for improvements from chronic symptoms.
Resolution rates have been shown to lead to significant improvements in QoL as reported in a previous trial. 6 This follow-up study is the first to report on the long term use and outcome of nasal irrigation. From the families whom we were able to contact for prospective follow-up, we found that more than half reported self-initiated use of saline nasal irrigation for recurrent symptoms even without making another appointment to see otolaryngology or any other physicians. Most families report that they find it useful at least some of the times whenever their child is able to irrigate. Our data suggest that once nasal irrigation is used as a treatment modality for pediatric CRS, parents and caretakers are likely to utilize it again for recurrent symptoms.
Limitations
This study has several limitations. First, all patient subjects were taken from a single clinic setting. Second, our phone follow-up survey was achieved in about 60% of all patients and families in this cohort. Despite multiple attempts to contact families based on the home and/or cell phone numbers available to us, and leaving messages, many calls were unreturned and some numbers were either disconnected or no longer in service. Parents who had a favorable experience may have been more likely to respond to the survey request.
Another limitation is recall bias, an inherent concern for any long-term follow-up. To address this we asked the parents/caretakers to estimate the frequency and duration of irrigation regimens in the past 12 months. Parents and caretakers who responded were keenly aware of their children's medical history and interventions in the previous 12 months and were able to provide answers to the best of their recall. Approximately 70% of parents recalled successful reversal of symptoms after initial experience using nasal irrigation, similar to the 65% who reported complete resolution of symptoms at the initial follow-up after 6 weeks of once daily irrigation. The consistency in parental report of treatment "success" after use of nasal irrigation supports the long term efficacy of nasal irrigation in symptoms resolution. We acknowledge the limitations inherent to the retrospective part of reviewing this cohort. One example is the information on frequency of prescribed and use of oral antibiotics by other providers, which when recorded by the pediatric otolaryngologist during the office visit is entirely dependent on what was reported by parents and caretakers. As we have moved to electronic medical record in the outpatient setting in the past 22 months, we anticipate that in the future we can better capture relevant data prospectively and continue to gain insights into patterns of medication prescription and utilization. We found no statistically significant differences in baseline characteristics, Lund-Mackay scores pre and post-irrigation, symptoms resolution after the initial 6 weeks of nasal irrigation between those who completed the long-term follow-up versus those we were unable to contact.
One of the greatest limitations of this current study is that we did not prospectively collect sinonasal-5 (SN-5) quality of life surveys in this entire group pre and post irrigation treatment. However, based on our previous published results and the senior authors experience from parental reports at follow-up visit, we believe that if such data were available, it would likely demonstrate significant improvement in overall quality of life after 6 weeks of once daily irrigation.
The sample size of the study may not be high enough to detect any differences when comparing those that we contacted to those we were unable to contact. While the results of a 6 week treatment period could be confounded by natural resolution or use of other treatments, due to consistent follow-up after 6 weeks of irrigation, the senior author confirms in each case that no other medications or treatment methods were likely responsible for the resolution of symptoms and post irrigation CT scan findings in these patients. While not all patients had a post-treatment CT scan report, the statistically significant reduction in Lund Mackay scores based on the 70 patients who did have pre-and post-treatment scans supports our experience and conclusions that nasal irrigation is highly effective for treating pediatric CRS. We had hoped to determine predictive factors of treatment outcomes based on irrigation, but this was not possible due to high rates of improvement among the majority of the subjects.
Clinical Importance
CT scans and 21 days of oral systemic antibiotics for the treatment of "sinus" infection continue to be the primary approaches to management of CRS. . Given that parents/caretakers usually state that these children are not febrile, nor do they miss school or other activities, and their children continue to function despite the quality of life impairments due to these symptoms, once daily saline irrigation for 6 weeks should be the recommended initial treatment for children with suspected CRS. CT imaging can be reserved for only those who do not experience moderate or complete symptom resolution. CT scans may also be necessary for planning of limited FESS as the definitive treatment in cases of exhausting all medical therapies. 3 Whenever CT imaging is necessary, a low-dose radiation protocol can be used, which scans at an equivalent of almost 1/7 th the standard dose of radiation received from prior protocols for CT sinus imaging. 29 These changes are important to minimize radiation exposure in children.
It is also important to counsel families on this opportunity for their otherwise healthy children not to consume medications unnecessarily. This follow-up study is the first to report on the long term use and outcome of nasal irrigation. Our data suggest that once nasal irrigation is used as a treatment modality for pediatric CRS, parents and caretakers are likely to utilize it again for recurrent symptoms. This is important to empower patients and families to treat symptoms without overutilization of the health care system and use of multiple medications.
As CRS remains a source of significant medical expenditure, an undoubtedly important Further studies could also be performed to address the cost-effectiveness of using sinus irrigation compared to sinus surgery.
Conclusion
Nasal irrigation is effective as a first line treatment for pediatric CRS and also useful for recurring symptoms. Use of once daily nasal irrigation for a 6 week-period is effective and leads to symptom resolution as well as minimizes need for sinus surgery. Patients with symptoms of
